Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing.

about

Harnessing the power of Vδ2 cells in cancer immunotherapy Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner.Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities.

P2860

Q27027547-156DBC13-925F-405B-8392-D3BF6AC2CA89 Q40213985-FA778418-236B-4637-B99F-1E2CE53936EB Q50144881-B0DC6B65-F89F-462E-A757-AC4544433060

P2860

Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing.

Item

http://www.wikidata.org/entity/Q38986536

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Zoledronic acid causes γδ T ce ...... -modulate inflammatory homing.

@en

type

Item

label

Zoledronic acid causes γδ T ce ...... -modulate inflammatory homing.

@en

prefLabel

Zoledronic acid causes γδ T ce ...... -modulate inflammatory homing.

@en

P1476

Zoledronic acid causes γδ T ce ...... -modulate inflammatory homing.

@en

P2093

Angus G Dalgleish

http://www.w3.org/2001/XMLSchema#string

Daniel W Fowler

http://www.w3.org/2001/XMLSchema#string

John Copier

http://www.w3.org/2001/XMLSchema#string

Mark D Bodman-Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset

What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

A rapid crosstalk of human gammadelta T cells and monocytes drives the acute inflammation in bacterial infections

New bisphosphonates in the treatment of bone diseases.

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

The use of dendritic cells in cancer immunotherapy.

Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma.

Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.

Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells

P304

539-549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IMM.12331

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24912747

http://www.w3.org/2001/XMLSchema#string

P932

4253502

http://www.w3.org/2001/XMLSchema#string

Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing.

about

P2860

P2860

Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932